Rossmore Private Capital Novartis Ag Transaction History

Rossmore Private Capital

$804 Million
Q3 2024

A detailed history of Rossmore Private Capital transactions in Novartis Ag stock. As of the latest transaction made, Rossmore Private Capital holds 4,627 shares of NVS stock, worth $455,528. This represents 0.07% of its overall portfolio holdings.

Number of Shares

4,627

Previous 4,627 -0.0%

Holding current value

$455,528

Previous $492,000 8.13%

% of portfolio

0.07%

Previous 0.06%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$95.27 - $108.47 $25,341 - $28,853	266 Added 6.1%	4,627 $447,000
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $127,122 - $144,146	-1,374 Reduced 23.96%	4,361 $440,000
Q1 2023 May 02, 2023	SELL	$80.03 - $92.81 $8,003 - $9,281	-100 Reduced 1.71%	5,735 $527,000
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $28,709 - $35,157	-380 Reduced 6.11%	5,835 $529,000
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $402 - $468	-5 Reduced 0.08%	6,215 $525,000
Q1 2022 May 09, 2022	BUY	$80.11 - $90.62 $10,013 - $11,327	125 Added 2.05%	6,220 $546,000
Q4 2021 Feb 07, 2022	BUY	$79.7 - $88.13 $20,722 - $22,913	260 Added 4.46%	6,095 $533,000
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $56,514 - $62,421	663 Added 12.82%	5,835 $532,000
Q1 2021 May 10, 2021	BUY	$83.5 - $98.47 $12,107 - $14,278	145 Added 2.88%	5,172 $442,000
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $206,495 - $249,767	2,645 Added 111.04%	5,027 $475,000
Q3 2020 Nov 10, 2020	BUY	$82.14 - $91.0 $195,657 - $216,762	2,382 New	2,382 $207,000
Q1 2018 May 04, 2018	SELL	$70.39 - $84.15 $76,021 - $90,882	-1,080 Closed	0 $0
Q4 2017 Mar 15, 2018	BUY	$72.33 - $77.64 $78,116 - $83,851	1,080	1,080 $90.7 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rossmore Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Rossmore Private Capital with notifications on news.

Account

Rossmore Private Capital Novartis Ag Transaction History